These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6248457)

  • 1. Biological behaviour & antigenicity of mouse passaged & formol inactivated foot & mouth disease virus type Asia-1 in guineapigs.
    Saraswat KC; Sharma KN; Mehrotra PN
    Indian J Exp Biol; 1980 Mar; 18(3):275-8. PubMed ID: 6248457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of gamma radiation on the infectivity, antigenicity and immunogenicity of the foot-and-mouth disease virus].
    Frescura T; Massa D; Cardaras P
    Boll Ist Sieroter Milan; 1972; 51(2):109-17. PubMed ID: 4345590
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological studies with cell cultured aluminium hydroxide gel adsorbed formalin inactivated foot and mouth disease type Asia I monovalent vaccine.
    Negi BS; Kumar S
    Indian Vet J; 1970 Jul; 47(7):555-61. PubMed ID: 4318813
    [No Abstract]   [Full Text] [Related]  

  • 4. [The inactivation of foot-and-mouth disease virus by ethylethyleneimine and the use of the inactivated virus in the preparation of vaccines].
    Bauer K
    Zentralbl Bakteriol Orig; 1970 Apr; 213(3):285-97. PubMed ID: 4318509
    [No Abstract]   [Full Text] [Related]  

  • 5. [Routine physico-chemical testing of concentrated virulent and inactivated foot-and-mouth disease virus antigens].
    Adamowicz P; Guerche J; Galampoix J; Prunet P
    Dev Biol Stand; 1976; 35():301-10. PubMed ID: 198300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evalutation of some methods of assay of foot-and-mouth disease antigen for vaccines.
    Garland AJ; Mowat GN; Fletton B
    Dev Biol Stand; 1976; 35():323-32. PubMed ID: 198302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilizing the immunizing antigen of foot-and-mouth disease virus by fixation with formaldehyde.
    Rowlands DJ; Sangar DV; Brown F
    Arch Gesamte Virusforsch; 1972; 39(1):274-83. PubMed ID: 4344146
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of methyl glyoxal on infectivity and antigenicity of foot-and-mouth disease virus.
    Ghizatullina NK
    Acta Virol; 1976 Oct; 20(5):380-6. PubMed ID: 11665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the immunogenic potencies of purified inactivated foot-and-mouth disease virus particles with variable amounts of VP1 protein (author's transl)].
    Bernard S; Grosclaude J; Adamowicz P; Guerche J
    Ann Rech Vet; 1977; 8(1):79-94. PubMed ID: 195512
    [No Abstract]   [Full Text] [Related]  

  • 10. A simple quantitative microtest for determination of the complement fixing activity of foot-and-mouth disease virus.
    Petr G; Láznicka F
    Acta Virol; 1972 Mar; 16(2):133-40. PubMed ID: 4401070
    [No Abstract]   [Full Text] [Related]  

  • 11. [Foot-and-mouth virus component responsible for immunogenesis].
    Salazhov EL; Ivanov VS
    Veterinariia; 1970 Sep; 9():38-40. PubMed ID: 4323895
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antigenic properties of some strains of foot-and-mouth disease virus].
    Bazadze TsV
    Veterinariia; 1971 Aug; 9():34-5. PubMed ID: 4334672
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of antibodies in the antigenic variability of the foot-and-mouth disease virus].
    Salazhov EL; Avilov VS; Rebenkov AG
    Veterinariia; 1976; (9):31-2. PubMed ID: 186935
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunological aspects of foot-and-mouth disease virus (author's transl)].
    Pinto AA
    Arq Inst Biol (Sao Paulo); 1973; 40(3):181-95. PubMed ID: 4377405
    [No Abstract]   [Full Text] [Related]  

  • 15. Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines.
    Warrington RE; Cunliffe HR; Bachrach HL
    Am J Vet Res; 1973 Aug; 34(8):1087-91. PubMed ID: 4356910
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunogenic quality of foot-and-mouth disease virus.
    Strobbe R
    Dev Biol Stand; 1976; 35():311-21. PubMed ID: 198301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the physical properties of the immunizing antigen of foot-and-mouth disease virus and the effect of various inactivating agents on its structure.
    Wild TF; Brown F
    Arch Gesamte Virusforsch; 1968; 24(1):86-103. PubMed ID: 4301974
    [No Abstract]   [Full Text] [Related]  

  • 18. [Differences in the antigenic structure of strains of the foot-and-mouth disease virus].
    Sobko AI; Koshetsian EG; Kochergina MF; Shevardin AN; Perevozchikov VA
    Veterinariia; 1974 Sep; (9):36-8. PubMed ID: 4143073
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antigenic properties of the foot-and-mouth disease virus concentrated by polyethylene glycol].
    Sobko AI; Prokhorov VN; Sokolov LN; Koshetsian EG
    Veterinariia; 1973 May; 49(5):67-8. PubMed ID: 4353691
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of the radial immunodiffusion test in the study of foot-and-mouth disease viruses].
    Tekerlekov P
    Vet Med Nauki; 1981; 18(7):41-9. PubMed ID: 6283723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.